Quarterly report pursuant to Section 13 or 15(d)

Common Stock

v3.22.2.2
Common Stock
9 Months Ended
Sep. 30, 2022
Equity [Abstract]  
Common Stock

5. Common Stock

 

The Company has 150,000,000 shares of common stock, $0.001 par value per share, authorized as of September 30, 2022 and December 31, 2021, respectively. The Company had 8,143 shares issued and outstanding as of September 30, 2022 and December 31, 2021.

 

On October 11, 2022, the Company effected a reverse stock split of all outstanding shares of the Company’s common stock at a ratio of one-for-12. At the Company’s 2022 Annual Meeting of Stockholders, holders of a majority of the outstanding voting power approved an amendment to the Certificate of Incorporation of the Company to effect a reverse stock split of all outstanding shares of our common stock.

 

The holders of common stock are entitled to one vote for each share of common stock held.

 

The Company is party to the At-The-Market Offering Agreement, dated July 1, 2020 (“ATM Agreement”) with H.C. Wainwright & Co., LLC (“Wainwright”), pursuant to which the Company may issue and sell over time and from time to time, to or through Wainwright, up to $10,000,000 of shares of the Company’s common stock. During January 2021, the Company sold 85,833 shares of its common stock pursuant to the ATM Agreement for net proceeds of approximately $2,072,000. There were no sales under the ATM Agreement during the nine months ended September 30, 2022.

 

 

On May 4, 2021, the Company entered into an underwriting agreement with H.C. Wainwright & Co., LLC, pursuant to which the Company agreed to issue and sell 2,166,667 shares of the Company’s common stock at a public offering price of $18.48 per share, less underwriting discounts and commissions (the “Offering”). The Company received approximately $36.4 million in net proceeds from the Offering, after deducting underwriting discounts and estimated offering expenses. The Offering closed on May 7, 2021.